Disclosures for "Prevalent Gabapentinoid Use Among Medicare Beneficiaries with Acute Ischemic Stroke"
-
Julianne Brooks has nothing to disclose.
-
Mrs. Bustamante Rocha has nothing to disclose.
-
Maria Donahue has nothing to disclose.
-
Mr. Sankaranarayanan has nothing to disclose.
-
Author has nothing to disclose
-
Sebastien Haneuse has received personal compensation for serving as an employee of Harvard University. Sebastien Haneuse has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
-
Mrs. Tsai has received personal compensation for serving as an employee of Johnson&Johnson. Mrs. Tsai has stock in Johnson & Johnson.
-
Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .